Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Essen Biotech
Amgen
Takeda
Perspective Therapeutics
Second Life Therapeutics
VM Oncology, LLC
Tanabe Pharma America, Inc.
CRISPR Therapeutics
Stella Pharma Corporation
Immunitas Therapeutics
Cancer Research UK
NuCana plc
Medicenna Therapeutics, Inc.
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
Cancer Research UK
NGM Biopharmaceuticals, Inc
Gustave Roussy, Cancer Campus, Grand Paris
Shandong Cancer Hospital and Institute
Cybrexa Therapeutics
Aminex Therapeutics, Inc.
NextCure, Inc.
Cancer Research UK
NGM Biopharmaceuticals, Inc
Jacobio Pharmaceuticals Co., Ltd.
Coherent Biopharma (Hefei) Co., Ltd.
Cancer Research UK
Chongqing Precision Biotech Co., Ltd
Second Affiliated Hospital of Guangzhou Medical University
Cancer Research and Biostatistics Clinical Trials Consortium
CytomX Therapeutics
Genmab
Kineta Inc.
National Institutes of Health Clinical Center (CC)
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Gilead Sciences
Incyte Corporation
NKGen Biotech, Inc.
Seagen Inc.
Shenzhen BinDeBio Ltd.
Celldex Therapeutics
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
FeRx